BMGL
Basel Medical Group Ltd Ordinary Shares
There isn't enough reported data to score BMGL yet.
BMGL Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Weak | |
| Unavailable | |
| Unavailable |
BMGL's profitability is currently weak. There isn't enough data to rate its revenue, cash flow and balance sheet.
BMGL PE Valuation
BMGL has no meaningful PE right now: it lost money over the past year.
BMGL Forward outlook
There aren't enough analyst estimates for BMGL to show an outlook.
BMGL Earnings Per Share
BMGL Quarterly Revenue
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2025 | -98% | N/A |
BMGL Free Cash Flow
BMGL Total Shares
BMGL Net Leverage
BMGL's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
BMGL Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 28.1 | Oversold |
| Stochastic | 26.3 | Neutral |
BMGL's weekly RSI is 28 (oversold) and its Stochastic is 26 (neutral).
BMGL PE vs Healthcare Sector
BMGL has no meaningful PE right now: it lost money over the past year.
BMGL Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.75 | 85% below |
| 20 week MA | $4.86 | 88% below |
| 50 week MA | $6.68 | 91% below |
BMGL is in a downtrend: it's below all three of its weekly moving averages, and 91% below its 50-week average.
BMGL Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $50.0 | $7.32 | -85% |
| 2026 YTD | $7.32 | $0.57 | -92% |
BMGL has finished every year since 2025 lower, and it's down 92% so far in 2026.